David D. Allison - 16 Jun 2022 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC

Role
Director
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 17:00:26 UTC
Previous filing
20 Jul 2022
Next filing
20 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +12,789 $0.000000 12,789 16 Jun 2022 Common Stock 12,789 $8.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on June 16, 2023.